News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer
Kevin Kalinsky/winshipcancer.emory.edu
Jan 19, 2025, 07:17

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al., titled “Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial“ published on Journal of Clinical Oncology.

Authors: Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, Stephanie L. Graff, Kyong Hwa Park, Rinath Jeselsohn, Umut Demirci, Miguel Martin, Rachel M. Layman, Sara A. Hurvitz, Sarah Sammons, Peter A. Kaufman, Montserrat Muñoz, Jiun-I Lai, Holly Knoderer, Cynthia Sandoval, Aarti R. Chawla, Bastien Nguyen, Yanhong Zhou, Elizabeth Ravenberg, Lacey M. Litchfield, Lillian Smyth, Seth A. Wander.

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

“New at Journal of Clinical Oncology. Abemaciclib Plus Fulvestrant in Advanced Breast Cancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial.“

Aarti R. Chawla Abemaciclib Bastien Nguyen Breast Cancer cancer Cynthia Sandoval Dana-Farber’s Breast Oncology Center Elizabeth Ravenberg Erika Hamilton Fulvestrant Giampaolo Bianchini Holly Knoderer Jiun-I Lai Journal of Clinical Oncology Kevin Kalinsky Kyong Hwa Park Lacey M. Litchfield Lillian Smyth Miguel Martin Montserrat Muñoz OncoDaily Oncology Peter A Kaufman postMONARCH Trial Rachel M. Layman Rinath Jeselsohn Sara A. Hurvitz Sarah Sammons Seth A Wander Stephanie L. Graff Umut Demirci Yanhong Zhou
Special Coverage
Oncolibrary
Jun 8, 2025, 17:28
ASCO 2025 Plenary Highlights: Key Practice-Changing Data Across TOP 5 ATOMIC, MATTERHORN, SERENA-6, VERIFY, and NIVOPOSTOP Trials
Blog
Jun 8, 2025, 17:04
Kimryn Rathmell Highlighted BuckeyeThon Students Raising Pediatric Blood Cancer Awareness at Farmers Market
Career
Jun 8, 2025, 17:03
Herbert Loong Joined IASLC Communications Committee For the 2025-2027 Term
Insight
Jun 8, 2025, 17:00
Christian Rolfo Highlighted VISION Trial Findings on METex14 NSCLC Detection Using Liquid and Tissue Biopsies
Blog
Jun 8, 2025, 16:58
Wafaa M Rashed: Final Words to the Eighth Cohort of the Policy Advocacy in Genetics and Genomics Course
Insight
Jun 8, 2025, 16:57
Akhil Santhosh Reflected on Experience with Dana-Farber’s Breast Oncology Team Through ASCO IDEA Program
Insight
Jun 8, 2025, 16:55
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Insight
Jun 8, 2025, 16:53
Talha Badar Shared an Article Published in Blood, ASH Journal
Insight
Jun 8, 2025, 16:48
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Insight
Jun 8, 2025, 16:46
Giannis Mountzios Highlighted ASCO25 DeLLphi-304 Trial Featuring Tarlatamab Progress
Blog
Jun 8, 2025, 16:44
Mohammad Jad Moussa Joined 2025 KCA 81K Challenge for Kidney Cancer Awareness
Insight
Jun 8, 2025, 16:42
Rami Manochakian Highlighted ASCO Connection Article on Building a Career in Oncology Medical Education